Literature DB >> 15111314

Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.

Jeffrey L Mason1, Arrel Toews, Janell D Hostettler, Pierre Morell, Kinuko Suzuki, James E Goldman, Glenn K Matsushima.   

Abstract

To understand mechanisms that may underlie the progression of a demyelinated lesion to a chronic state, we have used the cuprizone model of chronic demyelination. In this study, we investigated the fate of oligodendrocytes during the progression of a demyelinating lesion to a chronic state and determined whether transplanted adult oligodendrocyte progenitors could remyelinate the chronically demyelinated axons. Although there is rapid regeneration of the oligodendrocyte population following an acute lesion, most of these newly regenerated cells undergo apoptosis if mice remain on a cuprizone diet. Furthermore, the oligodendrocyte progenitors also become progressively depleted within the lesion, which appears to contribute to the chronic demyelination. Interestingly, even if the mice are returned to a normal diet following 12 weeks of exposure to cuprizone, remyelination and oligodendrocyte regeneration does not occur. However, if adult O4+ progenitors are transplanted into the chronically demyelinated lesion of mice treated with cuprizone for 12 weeks, mature oligodendrocyte regeneration and remyelination occurs after the mice are returned to a normal diet. Thus, the formation of chronically demyelinated lesions induced by cuprizone appears to be the result of oligodendrocyte depletion within the lesion and not due to the inability of the chronically demyelinated axons to be remyelinated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111314      PMCID: PMC1615641          DOI: 10.1016/S0002-9440(10)63726-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter.

Authors:  J M Gensert; J E Goldman
Journal:  J Neurobiol       Date:  2001-08

2.  A2B5+ and O4+ Cycling progenitors in the adult forebrain white matter respond differentially to PDGF-AA, FGF-2, and IGF-1.

Authors:  J L Mason; J E Goldman
Journal:  Mol Cell Neurosci       Date:  2002-05       Impact factor: 4.314

3.  The protective role of nitric oxide in a neurotoxicant-induced demyelinating model.

Authors:  Heather A Arnett; Ron P Hellendall; Glenn K Matsushima; Kinuko Suzuki; Victor E Laubach; Paula Sherman; Jenny P-Y Ting
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

4.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Wallace W Tourtellotte; Richard Rudick; Bruce D Trapp
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

5.  The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation.

Authors:  Fraser J Sim; Chao Zhao; Jacques Penderis; Robin J M Franklin
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

6.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

7.  Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination.

Authors:  Jeffrey L Mason; Shouhong Xuan; Ioannis Dragatsis; Argiris Efstratiadis; James E Goldman
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

8.  Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system.

Authors:  Jacques Penderis; Simon A Shields; Robin J M Franklin
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

9.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

10.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

Authors:  M M Hiremath; Y Saito; G W Knapp; J P Ting; K Suzuki; G K Matsushima
Journal:  J Neuroimmunol       Date:  1998-12-01       Impact factor: 3.478

View more
  73 in total

1.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination.

Authors:  Jigisha R Patel; Erin E McCandless; Denise Dorsey; Robyn S Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.

Authors:  S J Crocker; R Bajpai; C S Moore; R F Frausto; G D Brown; R R Pagarigan; J L Whitton; A V Terskikh
Journal:  Neuropathol Appl Neurobiol       Date:  2011-10       Impact factor: 8.090

3.  Locomotor activity and anxiety status, but not spatial working memory, are affected in mice after brief exposure to cuprizone.

Authors:  Handi Zhang; Yanbo Zhang; Haiyun Xu; Lingyan Wang; Jinsong Zhao; Junhui Wang; Zhijun Zhang; Qingrong Tan; Jiming Kong; Qingjun Huang; Xin-Min Li
Journal:  Neurosci Bull       Date:  2013-08-29       Impact factor: 5.203

4.  Deleterious role of IFNgamma in a toxic model of central nervous system demyelination.

Authors:  Paula Maña; David Liñares; Sue Fordham; Maria Staykova; David Willenborg
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

6.  A cord blood monocyte-derived cell therapy product accelerates brain remyelination.

Authors:  Arjun Saha; Susan Buntz; Paula Scotland; Li Xu; Pamela Noeldner; Sachit Patel; Amy Wollish; Aruni Gunaratne; Tracy Gentry; Jesse Troy; Glenn K Matsushima; Joanne Kurtzberg; Andrew E Balber
Journal:  JCI Insight       Date:  2016-08-18

7.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

8.  Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

Authors:  Adam C Vana; Nicole C Flint; Norah E Harwood; Tuan Q Le; Marcus Fruttiger; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

Review 9.  Myelin repair strategies: a cellular view.

Authors:  Vittorio Gallo; Regina C Armstrong
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

10.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.